Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Calogero AE, Burgio G, Condorelli RA, Cannarella R, La Vignera S (2019) Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. Aging Male 22(1):12–19. https://doi.org/10.1080/13685538.2018.1434772
2. Pinto JD, He HG, Chan SW, Toh PC, Esuvaranathan K, Wang W (2015) Health-related quality of life and psychological well-being in patients with benign prostatic hyperplasia. J Clin Nurs 24(3–4):511–522. https://doi.org/10.1111/jocn.12636
3. Gravas S, Cornu JN, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C et al (2020) EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO) 2020. European Association of Urology Guidelines 2020 Edition. Arnhem, The Netherlands: European Association of Urology Guidelines Office
4. Parsons JK, Dahm P, Kohler TS, Lerner LB, Wilt TJ (2020) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2020. J Urol 204(4):799–804. https://doi.org/10.1097/JU.0000000000001298
5. Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C et al (2015) A Systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67(6):1066–1096. https://doi.org/10.1016/j.eururo.2014.06.017